safety & efficacy of nelarabine, pegylated asparaginase and venetoclax in frontline therapy of t-all
Published 2 years ago • 228 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
3:35
safety and efficacy of venetoclax-based regimens for aml
-
0:51
nelarabine as first-line treatment for t-cell all: facing the problem up-front
-
1:36
improve study update: safety and efficacy of venetoclax retreatment in r/r cll
-
1:12
the safety and efficacy of mb-106 for the treatment of waldenström’s macroglobulinemia
-
3:02
the role of asparaginase in the treatment of all
-
1:09
nelarabine in combination with etoposide and cyclophosphamide in r/r t-all
-
1:51
the safety and efficacy of retreatment with venetoclax plus rituximab in r/r cll
-
1:43
e7820 in combination with venetoclax in patients with splicing factor mutant myeloid malignancies
-
1:19
safety and efficacy of mb-106 for the treatment of r/r fl
-
4:45
safety and efficacy of obe-cel in r/r adult b-all: results of the pivotal felix study
-
2:41
safety and efficacy of actaly-cel™ in r/r pediatric b-all
-
2:57
linker-mm1: promising safety and efficacy of linvoseltamab in r/r multiple myeloma
-
0:57
safety and efficacy of pirtobrutinib in patients with r/r b-cell malignancies
-
2:23
nelarabine for r/r t-cell all
-
1:29
fundamentals of laboratory safety trailer
-
2:49
orthopedic adverse events among aya patients with all treated with asparaginase
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:08
unmet needs in t-all: targeted therapies & managing relapse
-
2:03
the safety and efficacy of avapritinib in patients with advanced systemic mastocytosis